OVERVIEW

Early Combination Therapy in the Treatment of Type 2 Diabetes is organized by Horizon CME and will be held from Dec 04, 2018 - Dec 04, 2019. This Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

Target Audience:
This CME initiative was designed for nurse practitioners, physician assistants, and primary care providers working in diabetes care.

Course Overview
This webcast will cover the current guideline recommendations for the treatment of type 2 diabetes and will review the benefits and risks of various classes of antihyperglycemic agents including SGLT-2 inhibitors, discuss considerations for early combination therapy, and strategies for reducing clinical inertia.

Learning Objectives:
• Review current guideline recommendations for the initiation and intensification of therapy in patient with type 2 diabetes.
• Discuss the benefits and risks of various classes of antihyperglycemic agents.
• Discuss clinical considerations for early combination therapy.
• Implement strategies to reduce clinical inertia in the treatment of patients with type 2 diabetes.

Additional details will be posted as soon as they are available.